Novo Nordisk prints €6bn after CEO departs
◆ Novo Nordisk brings €6bn trade days after CEO leaves ◆ Tranches priced with similar premiums ◆ No sign of investor fatigue for jumbo corporate trades
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: